Kiniksa Pharmaceuticals International (KNSA) Tax Rate (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported Tax Rate of 30.87% for Q1 2026, down 1427.0% on a YoY basis from 2.33% in Q1 2025, and down 20.8% quarter-over-quarter from 38.98% in Q4 2025.
Kiniksa Pharmaceuticals International (KNSA) Tax Rate (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International has reported Tax Rate for 10 years, with the latest figure at 30.87% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate fell 1427.0% year-over-year to 30.87%; the trailing twelve-month figure through Mar 2026 stood at 31.07% (down 74949.0% YoY), and the FY2025 full-year result was 33.6%, up 5833.0% from the prior year.
- Tax Rate for Q1 2026 stood at 30.87%, down from 38.98% in the prior quarter.
- The five-year high for Tax Rate was 1308.39% in Q2 2023, with the low at 379.5% in Q3 2022.
- Historically, Tax Rate has averaged 72.37% across 5 years, with a median of 2.7% in 2022.
- Annual changes were most pronounced in 2023 — Tax Rate jumped 131211 bps — and 2024, when it plunged 103878 bps.
- Kiniksa Pharmaceuticals International's Tax Rate stood at 2.7% in 2022, then tumbled by 466 bps to 15.27% in 2023, then surged by 669 bps to 86.95% in 2024, then slumped by 55 bps to 38.98% in 2025, then decreased by 21 bps to 30.87% in 2026.
- The last three Tax Rate figures came in at 30.87% (Q1 2026), 38.98% (Q4 2025), and 32.12% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 15.33% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.71% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 13.63% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -20.44% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 19.81% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 34.48% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -7.43% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 24.29% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 9.29% |
| 10 | Kiniksa Pharmaceuticals International | 3.76 Bn | 3.29 Bn | 193.47 Mn | 30.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.87% |
| Mar 31, 2026 | 30.87% |
| Dec 31, 2025 | 38.98% |
| Dec 31, 2025 | 38.98% |
| Sep 30, 2025 | 32.12% |
| Sep 30, 2025 | 32.12% |
| Jun 30, 2025 | 22.05% |
| Jun 30, 2025 | 22.05% |
| Mar 31, 2025 | 45.14% |
| Mar 31, 2025 | 45.14% |
| Dec 31, 2024 | 86.95% |
| Dec 31, 2024 | 86.95% |
| Sep 30, 2024 | -76.27% |
| Sep 30, 2024 | -76.27% |
| Jun 30, 2024 | 269.62% |
| Jun 30, 2024 | 269.62% |
| Mar 31, 2024 | -24.01% |
| Mar 31, 2024 | -24.01% |
| Dec 31, 2023 | -15.27% |
| Dec 31, 2023 | -15.27% |